Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
Multiple sclerosis (MS) affects everyone differently, so start by confirming your MS type with your doctor. Consider trusted sources like the National Multiple Sclerosis Society for education. Common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results